The biologic DMARDs rituximab and abatacept were associated with an increased risk for incident cancers in patients with RA ...

Introduction of biosimilars for the rheumatology drug adalimumab, whose original branded version Humira has long been a ...

AnaptysBio discontinues ANB032 for atopic dermatitis after a trial failure, refocusing on autoimmune assets with upcoming ...

Officials said Bhatia allegedly procured tablets of phenylbutazone, piroxicam and dexamethasone from several suppliers in ...

Most available therapies, like pain medication and steroid injections, only mask the symptoms and don’t slow the progression ...

The global rheumatoid arthritis drugs market was valued at $57,929 million in 2019, and is projected to reach $62,935 million by 2027, registering a CAGR of 2.8% from 2020 to 2027. Alarming rise in ...

Central to the research is the Magnetic Particle Imaging technology, a scanner with unparalleled precision in tracking ...

Former Emmerdale star Adam Thomas has shared an update on his journey with arthritis. The actor revealed in August last year ...

Blocking blood flow to the site of knee arthritis can reduce pain and potentially prevent the need for knee replacement ...

AbbVie acquired the drug through its $8.7 billion purchase of Cerevel Therapeutics last year as its rheumatoid arthritis drug Humira, once the world's best-selling treatment, faces a sharp fall in ...

Discover how Treg cell dysfunction fuels inflammation in arthritis and the innovative therapies targeting this paradox for ...